Close
Nordic 9Nordic 9

Meteva AS (investor - None)

See something wrong or missing? Let us know
Average round investment:25M USD
Average number per year:1.0
Distribution: 2016 (1)
Portfolio companies: Norway BerGenBio
Mostly invests in: Norway Norway (1) Biotech (1)

1 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Meteva AS

Name Criteria
Norway Sundt AS
52%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech
  • Similar business models: B2B
  • Common investees countries: Norway
  • Average number of deals per year: 1.0
Norway Ferd Capital
51%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech
  • Similar business models: B2B
  • Common investees countries: Norway
  • Average number of deals per year: 1.4
Norway Geveran Trading
51%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech
  • Similar business models: B2B
  • Common investees countries: Norway
  • Average number of deals per year: 1.5
Netherlands Aescap Ventures
48%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech
  • Similar business models: B2B
  • Average number of deals per year: 1.0
United Kingdom Agronomics Limited
48%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech
  • Similar business models: B2B
  • Average number of deals per year: 1.0
Sweden AP3
48%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech
  • Similar business models: B2B
  • Average number of deals per year: 1.0
Sweden AP4 - Fjärde AP-fonden
48%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech
  • Similar business models: B2B
  • Average number of deals per year: 1.0
Sweden Bengt Julander
48%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech
  • Similar business models: B2B
  • Average number of deals per year: 1.0
France Biocodex
48%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech
  • Similar business models: B2B
  • Average number of deals per year: 1.0
United States Bracket Capital
48%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech
  • Similar business models: B2B
  • Average number of deals per year: 1.0
Top